Quick-Med Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QMDT research report →
About the company
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products.
- CEO
- Gerald Reisman
- IPO
- 2002
- Employees
- 5
- HQ
- Gainesville, FL, US
Price Chart
- Market Cap
- $29.88K
- P/E
- -0.04
- P/S
- 0.03
- P/B
- -0.00
- EV/EBITDA
- -1.02
- Div Yield
- 0.00%
- Gross Margin
- 69.79%
- Op Margin
- -40.50%
- Net Margin
- -76.80%
- ROE
- 8.33%
- ROIC
- -974.59%
- Revenue
- $928.49K · -6.92%
- Net Income
- $-713,073 · 57.73%
- EPS
- $-0.02 · 57.74%
- Op Income
- $-376,075
- FCF YoY
- 99.91%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -55.91
- Avg Volume
- 48
Get TickerSpark's AI analysis on QMDT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 10,100 |
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 25,000 |
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Jan 30, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Jan 30, 13 | PHRONESIS PARTNERS L P | sell | 9,900 |
| Jan 11, 13 | PHRONESIS PARTNERS L P | sell | 10,000 |
| Jan 11, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Jan 8, 13 | PHRONESIS PARTNERS L P | sell | 3,000 |
| Jan 8, 13 | PHRONESIS PARTNERS L P | sell | 0 |
Our QMDT coverage
Recent articles, reports, and earnings notes.
No research on QMDT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QMDT report →Similar companies
Peers in the same neighborhood.